juglone and paclitaxel
juglone has been researched along with paclitaxel in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cao, S; Foster, C; Kingston, DG; Lazo, JS; Murphy, BT | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Bauer, M; Birk, J; Daiber, C; Garin-Chesa, P; Guilliard, B; Hobbie, S; Nar, H; Rettig, WJ; Rippmann, JF; Schnapp, A | 1 |
| Akutsu, H; Kimura, H; Lee, SW; Masui, S; Nagashima, Y; Nishi, M; Perrem, K; Quinn, G; Ryo, A; Sakai, Y; Umezawa, A; Yamamoto, N | 1 |
| Che, D; Jin, X; Lv, H; Zhang, Y; Zhang, Z | 1 |
Other Studies
5 other study(ies) available for juglone and paclitaxel
| Article | Year |
|---|---|
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
Topics: cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Cyclic S-Oxides; Dual Specificity Phosphatase 1; Dual Specificity Phosphatase 6; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Naphthoquinones; Spectrometry, Mass, Electrospray Ionization | 2009 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Catalysis; Cell Line; Cell Nucleus; Cell Survival; Chromatin; Cloning, Molecular; Enzyme Inhibitors; Histones; Humans; Interphase; Kinetics; Microscopy, Fluorescence; Mitosis; Mutation; Naphthoquinones; NIMA-Interacting Peptidylprolyl Isomerase; Paclitaxel; Peptidylprolyl Isomerase; Phosphorylation; Proline; Protein Structure, Tertiary; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 2000 |
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Topics: Animals; Breast Neoplasms; CD24 Antigen; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cellular Reprogramming; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Dactinomycin; Drug Resistance, Neoplasm; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Induced Pluripotent Stem Cells; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mammary Glands, Human; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; Proto-Oncogene Proteins c-myc; Pyrans; SOXB1 Transcription Factors; Spheroids, Cellular | 2014 |
Juglone loaded poloxamer 188/phospholipid mixed micelles evaluated in vitro and in vivo in breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Humans; Micelles; Naphthoquinones; Paclitaxel; Phospholipids; Poloxamer | 2016 |